Beranda › Gangguan Depresi Mayor
Uji klinis Gangguan Depresi Mayor yang merekrut di AS
156 studi untuk Gangguan Depresi Mayor merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY37 studi
- Boston, MA31 studi
- Atlanta, GA25 studi
- Philadelphia, PA23 studi
- Orlando, FL19 studi
- Miami, FL18 studi
- Tampa, FL17 studi
- Chicago, IL17 studi
- Houston, TX16 studi
- San Diego, CA16 studi
- Little Rock, AR14 studi
- Orange, CA13 studi
- Las Vegas, NV13 studi
- Austin, TX13 studi
- Glendale, CA12 studi
- Jacksonville, FL12 studi
- Concord, CA12 studi
- Los Angeles, CA12 studi
- Washington, DC11 studi
- Grand Prairie, TX11 studi
- Cincinnati, OH11 studi
- Bellevue, WA10 studi
- Newton, MA10 studi
- Baltimore, MD9 studi
- Hartford, CT9 studi
- O'Fallon, MO9 studi
- Birmingham, AL9 studi
- Oklahoma City, OK9 studi
- Brooklyn, NY9 studi
- Oceanside, CA9 studi
- Dallas, TX9 studi
- Hialeah, FL8 studi
- Cleveland, OH8 studi
- Columbus, OH8 studi
- Phoenix, AZ8 studi
- San Bernardino, CA8 studi
- San Francisco, CA8 studi
- Everett, WA8 studi
- Hollywood, FL8 studi
- Staten Island, NY7 studi
Berdasarkan negara bagian
- Alabama15 studi
- Arizona13 studi
- Arkansas15 studi
- California52 studi
- Colorado10 studi
- Connecticut16 studi
- Distrik Columbia3 studi
- Florida32 studi
- Georgia33 studi
- Idaho3 studi
- Illinois20 studi
- Indiana4 studi
- Iowa5 studi
- Louisiana5 studi
- Maryland21 studi
- Massachusetts45 studi
- Michigan5 studi
- Minnesota7 studi
- Mississippi3 studi
- Missouri16 studi
- Nebraska3 studi
- Nevada13 studi
- New Jersey10 studi
- New Mexico4 studi
- New York48 studi
- North Carolina12 studi
- Ohio29 studi
- Oklahoma12 studi
- Oregon5 studi
- Pennsylvania27 studi
- South Carolina8 studi
- Tennessee6 studi
- Texas38 studi
- Utah14 studi
- Virginia7 studi
- Washington21 studi
- Wisconsin3 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Menerima pesertaFase 3
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07573176Natural History of Depression, Bipolar Disorder and Suicide Risk
Menerima pesertaStudi observasional
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06462196A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07775300Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
Menerima peserta
Usia 22 hingga 85 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07594483Precision Depression Adalimumab Trial
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07845604JAK Signaling in Depression
Menerima pesertaFase 2
Usia 25 hingga 55 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07003997Characterization and Treatment of Adolescent Depression
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 11 hingga 25 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT03388606A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07621237Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Menerima pesertaFase 3
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06559306A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Menerima pesertaFase 3
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07227454Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06830044Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
Menerima pesertaFase 2Sukarelawan sehat diterima
Usia 8 hingga 65 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT00018057Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT03065335DBS for TRD With the Medtronic Percept PC
Menerima peserta
Usia 25 hingga 70 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05773755The Medically Tailored Groceries and Mental Health Study
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07779707Accelerated TMS for Perinatal Depression
Menerima peserta
Usia 18 hingga 55 · Wanita · Diperbarui 18 Sep 2026 · NCT06968390A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07105111Lumateperone for Late-Life Depression
Menerima pesertaFase 3
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07623135Pattern Separation in Major Depressive Disorder
Menerima pesertaFase 1
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07139834Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07217223Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 21 hingga 45 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06480201A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07065240Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06511908Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.